Consern Pharma Pvt. Ltd. (WHO - GMP Certified Company) Urgently requires unit head for its manufacturing unit having tablets & capsule section at ludhiana
HLL Lifecare Limited is a Mini Ratna Company of Govt. of India under the Ministry of Health & Family Welfare. HLL, a schedule B Public Sector Enterprise is today a multi product, multi unit organization addressing various public health challenges. The company with five manufacturing units and marketing offices throughout the country is engaged in the manufacturing and marketing of a wide range of contraceptives and healthcare products.
Cactus Communications is a pioneer in language services, serving more than 60,000 clients across 116 countries.
We engage a global team of highly skilled freelance editors who are experts in various academic fields. CACTUS is honoured to be ranked 15th (after a screening of more than 40,000 companies) on the 2016 list of Top 100 Companies for Remote/Freelance Jobs (Forbes Article).
We’re currently looking for specialist freelance copyeditors and substantive editors. Apply now and register instantly!
ABOUT AUTHORS: NG Dhawan*1, Manisha Mavai2, Priyanka Bishnoi3, Raaz K Maheshwari3 1Amity Institute of Environmental Sciences, Amity University, Noida, UP, India 2Department of Botany Physiology, AIIMS, Jodhpur, Rajasthan, India 3Department of Botany & Biotechnology, University of Rajasthan, Rajasthan, India 4Department of Chemistry, SBRM Govt PG College, Nagaur, India *rkmgreenchem.jaipur@gmail.com
ABSTRACT
The genetic resources and indigenous communities traditional knowledge of developing countries is being exploited by the Developed countries in the name of patents for inventions that are derived from genetic resources. The exploitation of genetic resources and indigenous communities traditional knowledge by the developed countries in the name of patents on the inventions derived from those genetic resources is actually bio-piracy. Protection of the TK of the local and indigenous communities appears to be one of the most debatable and complex issues. This paper brings out the role of domestic IPR constitution that looks to protect traditional system of medicine and associated TK in Indian sub-continent. Further, it attempts to validate the necessity of introduction of a national TKDL, which can be utilized as an evidence of the 'prior art' by the examiners of patent offices, nationally as well as internationally. Thus, it aims to address the concerns relating to the creation of TKDL in India.
ABOUT AUTHORS: Vikram S. Chauhan1*, Bina Rani2, Priyanka Bishnoi3, Raaz K. Maheshwari3
1Department of Botany, SBRM Govt PG College, Nagaur, Rajasthan, India 2Department of Engineering chemistry & Environmental Engineering, Poornima College of Engineering, Jaipur, India 3Department of Chemistry, SBRM Government PG College, Nagaur, Rajasthan, India *vikkysingh2000@yahoo.com; rkmgreenchem.jaipur@gmail.com
ABSTRACT
With the advent of modern times, stress and pollution have led to major effect on rise of death toll due to chronic diseases. Such diseases are major cause of concern for the medical society. Lycopene, a carotenoid pigment found in tomatoes and its products has antioxidant properties due to the presence of numerous double bonds. Increased consumption of lycopene containing diet has been proposed to offer a protection against many types of cancers and cardio-vascular diseases. Its potential role as nutraceutical has been suggested in many studies. The present review deals with fundamental biochemistry, bio-availability and benefits of lycopene rich diet and its relation with some chronic diseases like various forms of cancers and cardiovascular diseases.
Applications are invited from male & female Indian citizens for appointment of following posts (Group 'B' & 'C' Combatised) for Para Medical Staff in the Border Security Force, Ministry of Home Affairs, Government of India. The post is temporary but likely to become permanent.
Nextus is a dynamic organization offering Strategic Management & HR Consulting Solutions. We offer a range of services covering Business Consultancy, Communication Planning, Recruitment & Training. With a focused Pharmaceutical & Healthcare Industry Practice, Nextus is one of fastest growing Strategic Business Consultancy companies in India, with comprehensive Recruitment & Training solutions. We bring deep, functional expertise to focus on client’s critical issues and opportunities. Our systematic and result-oriented approach helps our clients achieve their goals in cost-effective and timely manner.
ABOUT AUTHORS: Suresh Rewar1*, Dashrath Mirdha2, Prahlad Rewar3 1Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan, 2Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India 3Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India sureshrewar1990@gmail.com
ABSTRACT
A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.
ABOUT AUTHORS: Suresh Rewar1*, Dashrath Mirdha2, Prahlad Rewar3 1Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan, 2Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India 3Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India sureshrewar1990@gmail.com
ABSTRACT
A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.